Award

2019YFC1708900

Funder: National Key Research and Development Program of China

Funded outputs count: 14

Funder award ID: 2019YFC1708900

OpenAlex ID: G1671533835

UPLC‐Q‐TOF‐MS‐Driven Systems Pharmacology Analysis of Dengzhan Shengmai Capsule Against Heart Failure: Integrating Serum/Tissue Distribution, Molecular Docking, and scRNA‐seq Evidence

2026 · Zeyu Li, Xiaofang Yang, et al. · Biomedical Chromatography

Identifying the target, mechanism, and agonist of α-ketoglutaric acid in delaying mesenchymal stem cell senescence

2025 · Zhao Cui, Jiameng Li, et al. · Cell Reports · 20

Targeted arginine metabolomics combined with metagenomics revealed the potential mechanism of Pueraria lobata extract in treating myocardial infarction

2024 · Bojiao Yi, Yurou Zhao, et al. · Journal of Chromatography A · 3

Dengzhanshengmai capsule alleviates heart failure and concomitantly decreases phenylacetylglutamine level, interacting with the intestinal microflora in rats

2023 · Bojiao Yi, Pin Zhang, et al. · Microbial Biotechnology · 12

Ethanol extract of Pueraria lobata improve acute myocardial infarction in rats via regulating gut microbiota and bile acid metabolism

2023 · Pin Zhang, Zhengyu Fang, et al. · Phytotherapy Research · 19

Defect-buffering cellular plasticity increases robustness of metazoan embryogenesis

2022 · Long Xiao, Duchangjiang Fan, et al. · Cell Systems · 23

Yi-Xin-Shu capsule ameliorates cardiac hypertrophy by regulating RB/HDAC1/GATA4 signaling pathway based on proteomic and mass spectrometry image analysis

2022 · Minyu Zhang, Feifei Guo, et al. · Phytomedicine · 22

Time-related accurate investigation of multicomponent drug interventions in heart failure

2022 · Menglan Wang, Yue Wu, et al. · Phytomedicine Plus · 3

Rapid Characterization and Identification of the Chemical Constituents and the Metabolites of Du-Zhi Pill Using Uhplc Coupled with Quadrupole Time-of-Flight Mass Spectrometry

2022 · Huaqing Lai, Yi Ouyang, et al. · Journal of Chromatography B · 16

Signature network-based survey of the effects of a traditional Chinese medicine on heart failure

2021 · Yue Wu, Menglan Wang, et al. · Journal of Ethnopharmacology · 9

Serum Metabolomic Analysis of Coronary Heart Disease Patients with Stable Angina Pectoris Subtyped by Traditional Chinese Medicine Diagnostics Reveals Biomarkers Relevant to Personalized Treatments

2021 · Na Guo, Peili Wang, et al. · Frontiers in Pharmacology · 10

Urinary metabolomic profiling reveals difference between two traditional Chinese medicine subtypes of coronary heart disease

2021 · Na Guo, Yangan Chen, et al. · Journal of Chromatography B · 9

Discovery of 4-arylthiophene-3-carboxylic acid as inhibitor of ANO1 and its effect as analgesic agent

2020 · Yuxi Wang, Jian Gao, et al. · Acta Pharmaceutica Sinica B · 18

Beneficial effects of sappanone A on lifespan and thermotolerance in Caenorhabditis elegans

2020 · Jingwei Zhao, An Zhu, et al. · European Journal of Pharmacology · 27